Robust & Flexible Cell Lines That Fit Your Strategy

Discover AbZelectPRO™ | AbZelectPRO™-KO | AbZelectPRO™-KO+ – For Tailored Standalone CLD or Fully Integrated to GMP Manufacture

Our two new mammalian platforms offer two new cell lines that deliver a new standard of excellence.

For a new complex biologic therapeutic, developing a robust, high-yielding cell line is a foundational step in the development journey to IND. However, the path to a successful cell line is not always straightforward and can be a complex. A timely and multi-faceted process that requires careful planning, integration and execution is needed so that your pathway to the clinic is de-risked and streamlined.

Over two decades of expertise in providing leading cell line development services, coupled with our state-of-the-art technologies, ensures that every step of the process is meticulously planned and executed.

Leverage the AbZelectPRO™ Advantage

Our AbZelectPRO™ CLD platforms have been developed with a focus on optimizing three key areas that improve efficiency:

• The vector — Codon optimized transgenes using ProteoNic’s 2G UNic® vector technology
• The host cell line — CHO-K1 (AbZelectPRO™), CHOSOURCE™ GS KO (AbZelectPRO™-KO), or CHOSOURCE™ GS KO ADCC+ (AbZelectPRO™-KO+) host cell lines
• The process — Optimized process, from transfection to stable pool and clone generation to maximize efficiencies and reduce timelines

Download Info Sheet

Achieve More From Your Cell Line By Partnering With Abzena

As a complex biologic and bioconjugates CDMO with over two decades of experience in CLD, Abzena has expertise in expressing biologics ranging from mAbs, antibody fragments, fusion proteins, and vaccines. Having developed hundreds of cell lines, we are here to help you accomplish your goals. We are ready to progress your program to its next target inflection point with greater success.

Contact our experts today to find out more about AbZelectPRO™,, AbZelectPRO™-KO and AbZelectPRO™-KO+.